Sign in
TRXB Stock Price, Chart, Stats & News
TRex Bio Inc.
Save
TRex Bio Inc. (TRXB) does not currently pay a dividend.
116.70M
Market cap
–
Current P/E
–
Forward P/E
TRXB chart
Price history is unavailable
We don't have enough price data for TRXB to draw a chart yet.
About
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.
Similar securities
Based on sector and market capitalization
Report issue